Upfront Diagnostics


Programme

Accelerate alumni

Sector

Healthcare/Pharma/Biotech



Programme
Accelerate Alumni (Cohort 15)
Founded in
2017
Total funds raised
£2.5 million
Employees
1-10
Industry
Healthcare, pharma, biotech

Upfront Diagnostics has discovered and validated novel blood biomarkers for the detection of stroke patients suffering from a large vessel occlusion. Biomarkers enable faster and more accurate stroke diagnosis which will decrease the time to treatment, reducing disabilities and deaths after a stroke. Upfront Diagnostics owns a family of patentswhich protects novel biomarkers for stroke detection.

Get in touch

Visit Upfront Diagnostics' website

Top